ASSET PURCHASE AGREEMENTAsset Purchase Agreement • March 30th, 2020 • Merrimack Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 30th, 2020 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”) is entered into as of March 27, 2020, by and between Celator Pharmaceuticals, Inc., a Delaware corporation (the “Buyer”), and Merrimack Pharmaceuticals, Inc., a Delaware corporation (the “Seller”).